Association of a FGFR-4 gene polymorphism with bronchopulmonary dysplasia and neonatal respiratory distress

Disease Markers

Volumn 35, Issue 6, 2013, Pages 633-640

  Rezvani, Milad ^a   Wilde, Juliane ^a   Vitt, Patricia ^a   Mailaparambil, Beena ^a   Grychtol, Ruth ^a   Krueger, Marcus ^a   Heinzmann, Andrea ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

FIBROBLAST GROWTH FACTOR 18; FIBROBLAST GROWTH FACTOR 3; FIBROBLAST GROWTH FACTOR RECEPTOR 2; FIBROBLAST GROWTH FACTOR RECEPTOR 3; FIBROBLAST GROWTH FACTOR RECEPTOR 4; GELATINASE A; GELATINASE B; GENOMIC DNA; INTERSTITIAL COLLAGENASE; KERATINOCYTE GROWTH FACTOR; MACROPHAGE ELASTASE; MATRIX METALLOPROTEINASE 16; MEMBRANE PROTEIN; SIGNAL REGULATORY PROTEIN ALPHA; THYROID TRANSCRIPTION FACTOR 1; UNCLASSIFIED DRUG;

AIRWAY PRESSURE; AMINO ACID SUBSTITUTION; ARTICLE; ARTIFICIAL VENTILATION; CAUCASIAN; CONTROLLED STUDY; DNA POLYMORPHISM; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC RISK; GENETIC VARIABILITY; GENOTYPE; HUMAN; INTRON; LUNG DYSPLASIA; NEONATAL RESPIRATORY DISTRESS SYNDROME; NEWBORN; PERINATAL PERIOD; POLYMERASE CHAIN REACTION; PREMATURITY; PRIORITY JOURNAL; PROMOTER REGION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SINGLE NUCLEOTIDE POLYMORPHISM; UPREGULATION;

BRONCHOPULMONARY DYSPLASIA; CHILD, PRESCHOOL; GENE FREQUENCY; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INFANT; INFANT, NEWBORN; INFANT, PREMATURE; MATRIX METALLOPROTEINASES, SECRETED; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTOR, FIBROBLAST GROWTH FACTOR, TYPE 4; RESPIRATORY DISTRESS SYNDROME, NEWBORN; SEQUENCE ANALYSIS, DNA;

EID: 84888871450     PISSN: 02780240     EISSN: 18758630     Source Type: Journal    
DOI: 10.1155/2013/932356     Document Type: Article

References (48)

1. Northway W. H. Jr., Rosan R. C., Porter D. Y., Pulmonary disease following respirator therapy of hyaline-membrane disease. Bronchopulmonary dysplasia. The New England Journal of Medicine 1967 276 7 357 368 2-s2.0-0014208018
2. Walsh M. C., Yao Q., Gettner P., Hale E., Collins M., Hensman A., Everette R., Peters N., Miller N., Muran G., Auten K., Newman N., Rowan G., Grisby C., Arnell K., Miller L., Ball B., McDavid G., National Institute of Child Health and Human Development Neonatal Research Network, Impact of a physiologic definition on bronchopulmonary dysplasia rates. Pediatrics 2004 114 5 1305 1311 2-s2.0-16644364184 10.1542/peds.2004-0204
3. Chye J. K., Gray P. H., Rehospitalization and growth of infants with bronchopulmonary dysplasia: a matched control study. Journal of Paediatrics and Child Health 1995 31 2 105 111 2-s2.0-0028955378
4. Smith V. C., Zupancic J. A. F., McCormick M. C., Croen L. A., Greene J., Escobar G. J., Richardson D. K., Rehospitalization in the first year of life among infants with bronchopulmonary dysplasia. Journal of Pediatrics 2004 144 6 799 803 2-s2.0-3042794765 10.1016/j.jpeds.2004.03.026
5. Schmidt B., Asztalos E. V., Roberts R. S., Robertson C. M. T., Sauve R. S., Whitfield M. F., Trial of Indomethacin Prophylaxis in Preterms (TIPP) Investigators, Impact of bronchopulmonary dysplasia, brain injury, and severe retinopathy on the outcome of extremely low-birth-weight infants at 18 months: results from the trial of indomethacin prophylaxis in preterms. The Journal of the American Medical Association 2003 289 9 1124 1129 2-s2.0-0037420266 10.1001/jama.289.9.1124
6. Jobe A. H., Bancalari E., Bronchopulmonary dysplasia. The American Journal of Respiratory and Critical Care Medicine 2001 163 7 1723 1729 2-s2.0-0034961202
7. Kinsella J. P., Greenough A., Abman S. H., Bronchopulmonary dysplasia. The Lancet 2006 367 9520 1421 1431 2-s2.0-33646137788 10.1016/S0140-6736(06) 68615-7
8. Bhandari V., Bizzarro M. J., Shetty A., Zhong X., Page G. P., Zhang H., Ment L. R., Gruen J. R., Familial and genetic susceptibility to major neonatal morbidities in preterm twins. Pediatrics 2006 117 6 1901 1906 2-s2.0-33745302079 10.1542/peds.2005-1414
9. Lavoie P. M., Pham C., Jang K. L., Heritability of bronchopulmonary dysplasia, defined according to the consensus statement of the national institutes of health. Pediatrics 2008 122 3 479 485 2-s2.0-51649115601 10.1542/peds.2007-2313
10. Coalson J. J., Pathology of new bronchopulmonary dysplasia. Seminars in Neonatology 2003 8 1 73 81 2-s2.0-0037300312 10.1016/S1084-2756(02)00193-8
11. Greenlee K. J., Werb Z., Kheradmand F., Matrix metalloproteinases in lung: multiple, multifarious, and multifaceted. Physiological Reviews 2007 87 1 69 98 2-s2.0-33846785537 10.1152/physrev.00022.2006
12. Kheradmand F., Rishi K., Werb Z., Signaling through the EGF receptor controls lung morphogenesis in part by regulating MT1-MMP-mediated activation of gelatinase A/MMP2. Journal of Cell Science 2002 115 4 839 848 2-s2.0-0037084399
13. Harijith A., Choo-Wing R., Cataltepe S., Yasumatsu R., Aghai Z. H., Janèr J., Andersson S., Homer R. J., Bhandari V., A role for matrix metalloproteinase 9 in IFN γ -mediated injury in developing lungs: relevance to bronchopulmonary dysplasia. The American Journal of Respiratory Cell and Molecular Biology 2011 44 5 621 630 2-s2.0-79955491537 10.1165/rcmb.2010-0058OC
14. Hadchouel A., Decobert F., Franco-Montoya M., Halphen I., Jarreau P., Boucherat O., Martin E., Benachi A., Amselem S., Bourbon J., Danan C., Delacourt C., Matrix metalloproteinase gene polymorphisms and bronchopulmonary dysplasia: identification of MMP16 as a new player in lung development. PLoS ONE 2008 3 9 2-s2.0-52649167879 10.1371/journal.pone.0003188 e3188
15. Brauer P. R., MMPs-role in cardiovascular development and disease. Frontiers in Bioscience 2006 11 1 447 478 2-s2.0-32944473831 10.2741/1810
16. Shannon J. M., Hyatt B. A., Epithelial-mesenchymal interactions in the developing lung. Annual Review of Physiology 2004 66 625 645 2-s2.0-2342620855 10.1146/annurev.physiol.66.032102.135749
17. Sekine K., Ohuchi H., Fujiwara M., Yamasaki M., Yoshizawa T., Sato T., Yagishita N., Matsui D., Koga Y., Itoh N., Kato S., Fgf10 is essential for limb and lung formation. Nature Genetics 1999 21 1 138 141 2-s2.0-0032947346 10.1038/5096
18. Dionne C. A., Crumley G., Bellot F., Kaplow J. M., Searfoss G., Ruta M., Burgess W. H., Jaye M., Schlessinger J., Cloning and expression of two distinct high-affinity receptors cross-reacting with acidic and basic fibroblast growth factors. EMBO Journal 1990 9 9 2685 2692 2-s2.0-0025032508
19. Keegan K., Johnson D. E., Williams L. T., Hayman M. J., Isolation of an additional member of the fibroblast growth factor receptor family, FGFR-3. Proceedings of the National Academy of Sciences of the United States of America 1991 88 4 1095 1099 2-s2.0-0026020296
20. Partanen J., Mäkelä T. P., Eerola E., Korhonen J., Hirvonen H., Claesson-Welsh L., Alitalo K., FGFR-4, a novel acidic fibroblast growth factor receptor with a distinct expression pattern. EMBO Journal 1991 10 6 1347 1354 2-s2.0-0025778586
21. Powell P. P., Wang C., Horinouchi H., Shepherd K., Jacobson M., Lipson M., Jones R., Differential expression of fibroblast growth factor receptors 1 to 4 and ligand genes in late fetal and early postnatal rat lung. The American Journal of Respiratory Cell and Molecular Biology 1998 19 4 563 572 2-s2.0-0032186383
22. Weinstein M., Xu X., Ohyama K., Deng C. X., FGFR-3 and FGFR-4 function cooperatively to direct alveogenesis in the murine lung. Development 1998 125 18 3615 3623 2-s2.0-0031700905
23. Parker R. A., Lindstrom D. P., Cotton R. B., Evidence from twin study implies possible genetic susceptibility to bronchopulmonary dysplasia. Seminars in Perinatology 1996 20 3 206 209 2-s2.0-0029809766
24. Levit O., Jiang Y., Bizzarro M. J., Hussain N., Buhimschi C. S., Gruen J. R., Zhang H., Bhandari V., The genetic susceptibility to respiratory distress syndrome. Pediatric Research 2009 66 6 693 697 2-s2.0-73449095745 10.1203/PDR.0b013e3181bbce86
25. Gardai S. J., Xiao Y., Dickinson M., Nick J. A., Voelker D. R., Greene K. E., Henson P. M., By binding SIRP α or calreticulin/CD91, lung collectins act as dual function surveillance molecules to suppress or enhance inflammation. Cell 2003 115 1 13 23 2-s2.0-0141918823 10.1016/S0092-8674(03) 00758-X
26. Takenaka K., Prasolava T. K., Wang J. C. Y., Mortin-Toth S. M., Khalouei S., Gan O. I., Dick J. E., Danska J. S., Polymorphism in Sirpa modulates engraftment of human hematopoietic stem cells. Nature Immunology 2007 8 12 1313 1323 2-s2.0-36248956243 10.1038/ni1527
27. Boggaram V., Thyroid transcription factor-I (TTF-I/Nkx2.I/TITFI) gene regulation in the lung. Clinical Science 2009 116 1 27 35 2-s2.0-60549094652 10.1042/CS20080068
28. Mailaparambil B., Krueger M., Heizmann U., Schlegel K., Heinze J., Heinzmann A., Genetic and epidemiological risk factors in the development of bronchopulmonary dysplasia. Disease Markers 2010 29 1 1 9 2-s2.0-77957236640 10.3233/DMA-2010-0720
29. Zhu Y., Spitz M. R., Lei L., Mills G. B., Wu X., A single nucleotide polymorphism in the matrix metalloproteinase-1 promoter enhances lung cancer susceptibility. Cancer Research 2001 61 21 7825 7829 2-s2.0-0035503537
30. Joos L., He J. Q., Shepherdson M. B., Connett J. E., Anthonisen N. R., Pare P. D., Sandford A. J., The role of matrix metalloproteinase polymorphisms in the rate of decline in lung function. Human Molecular Genetics 2002 11 5 569 576 2-s2.0-0036501372
31. Sanger F., Nicklen S., Coulson A. R., DNA sequencing with chain-terminating inhibitors. Proceedings of the National Academy of Sciences of the United States of America 1977 74 12 5463 5467 2-s2.0-0017681196
32. Marttila R., Haataja R., Rämet M., Löfgren J., Hallman M., Surfactant protein B polymorphism and respiratory distress syndrome in premature twins. Human Genetics 2003 112 1 18 23 2-s2.0-0037208916 10.1007/s00439-002- 0835-y
33. van Sonderen L., Halsema E. F. W., Spiering E. J. H., Koppe J. G., Genetic influences in respiratory distress syndrome: a twin study. Seminars in Perinatology 2002 26 6 447 449 2-s2.0-12244290316 10.1053/sper.2002.37315
34. Myrianthopoulos N. C., Churchill J. A., Baszynski A. J., Respiratory distress syndrome in twins. Acta Geneticae Medicae et Gemellologiae 1971 20 2 199 204 2-s2.0-0015046365
35. Marttila R., Kaprio J., Hallman M., Respiratory distress syndrome in twin infants compared with singletons. The American Journal of Obstetrics and Gynecology 2004 191 1 271 276 2-s2.0-4043070735 10.1016/j.ajog.2003.11.020
36. Hallman M., Haataja R., Genetic basis of respiratory distress syndrome. Frontiers in Bioscience 2007 12 7 2670 2682 2-s2.0-34547101477 10.2741/2263
37. Hilgendorff A., Heidinger K., Pfeiffer A., Bohnert A., König I. R., Ziegler A., Merz C., Frey G., Chakraborty T., Gortner L., Bein G., Association of polymorphisms in the mannose-binding lectin gene and pulmonary morbidity in preterm infants. Genes and Immunity 2007 8 8 671 677 2-s2.0-36949024943 10.1038/sj.gene.6364432
38. Kazzi S. N. J., Kim U. O., Quasney M. W., Buhimschi I., Polymorphism of tumor necrosis factor-alpha and risk and severity of bronchopulmonary dysplasia among very low birth weight infants. Pediatrics 2004 114 2 e243 e248 2-s2.0-16544364886
39. Rocha G., Proença E., Areias A., Freitas F., Lima B., Rodrigues T., Alves H., Guimarães H., HLA and bronchopulmonary dysplasia susceptibility: a pilot study. Disease Markers 2011 31 4 199 203 2-s2.0-81055147532 10.3233/DMA-2011-0811
40. Manar M. H., Brown M. R., Gauthier T. W., Brown L. A. S., Association of glutathione-S-transferase-P1 (GST-P1) polymorphisms with bronchopulmonary dysplasia. Journal of Perinatology 2004 24 1 30 35 2-s2.0-0742306416 10.1038/sj.jp.7211020
41. Danan C., Jarreau P., Franco M., Dassieu G., Grillon C., Alsamad I. A., Lafuma C., Harf A., Delacourt C., Gelatinase activities in the airways of premature infants and development of bronchopulmonary dysplasia. The American Journal of Physiology-Lung Cellular and Molecular Physiology 2002 283 5 L1086 L1093 2-s2.0-0036838901
42. Schulz C. G., Sawicki G., Lemke R. P., Roeten B. M., Schulz R., Cheung P., MMP-2 and MMP-9 and their tissue inhibitors in the plasma of preterm and term neonates. Pediatric Research 2004 55 5 794 801 2-s2.0-1942437618 10.1203/01.PDR.0000120683.68630.FB
43. Dik W. A., van Kaam A. H. L. C., Dekker T., Naber B. A. E., Janssen D. J., Kroon A. A., Zimmermann L. J. I., Versnel M. A., Lutter R., Early increased levels of matrix metalloproteinase-9 in neonates recovering from respiratory distress syndrome. Biology of the Neonate 2006 89 1 6 14 2-s2.0-30644465559 10.1159/000088193
44. Tai A. L. S., Sham J. S. T., Xie D., Fang Y., Wu Y. L., Hu L., Deng W., Tsao G. S. W., Qiao G. B., Cheung A. L. M., Guan X. Y., Co-overexpression of fibroblast growth factor 3 and epidermal growth factor receptor is correlated with the development of nonsmall cell lung carcinoma. Cancer 2006 106 1 146 155 2-s2.0-29744456389 10.1002/cncr.21581
45. Zhao B., Chua S. S., Burcin M. M., Reynolds S. D., Stripp B. R., Edwards R. A., Finegold M. J., Tsai S. Y., DeMayo F. J., Phenotypic consequences of lung-specific inducible expression of FGF-3. Proceedings of the National Academy of Sciences of the United States of America 2001 98 10 5898 5903 2-s2.0-0035826698 10.1073/pnas.101116598
46. Hajitou A., Baramova E. N., Bajou K., Noë V., Bruyneel E., Mareel M., Collette J., Foidart J. M., Calberg-Bacq C. M., FGF-3 and FGF-4 elicit distinct oncogenic properties in mouse mammary myoepithelial cells. Oncogene 1998 17 16 2059 2071 2-s2.0-0032558733
47. Park M. S., Rieger-Fackeldey E., Schanbacher B. L., Cook A. C., Bauer J. A., Rogers L. K., Hansen T. N., Welty S. E., Smith C. V., Altered expressions of fibroblast growth factor receptors and alveolarization in neonatal mice exposed to 85% oxygen. Pediatric Research 2007 62 6 652 657 2-s2.0-36349017753 10.1203/PDR.0b013e318159af61
48. Srisuma S., Bhattacharya S., Simon D. M., Solleti S. K., Tyagi S., Starcher B., Mariani T. J., Fibroblast growth factor receptors control epithelial-mesenchymal interactions necessary for alveolar elastogenesis. The American Journal of Respiratory and Critical Care Medicine 2010 181 8 838 850 2-s2.0-77953045672 10.1164/rccm.200904-0544OC